<DOC>
	<DOCNO>NCT00005825</DOCNO>
	<brief_summary>RATIONALE : Drugs use chemotherapy use different way stop tumor cell divide stop grow die . Combining one drug may kill tumor cell . PURPOSE : Phase II trial study effectiveness combination chemotherapy treat patient stage IIIB stage IV non-small cell lung cancer .</brief_summary>
	<brief_title>Combination Chemotherapy Treating Patients With Stage IIIB Stage IV Non-small Cell Lung Cancer</brief_title>
	<detailed_description>OBJECTIVES : - Determine response rate duration response mitomycin , vinorelbine , cisplatin plus tretinoin patient stage IIIB IV non-small cell lung cancer . - Determine toxicity treatment regimen patient . - Determine survival patient treatment regimen . OUTLINE : Patients receive tretinoin orally twice daily 4 day start day 1 8 ; cisplatin IV 2 hour vinorelbine IV day 1 8 ; mitomycin IV ( course 1 3 ) day 1 . Treatment repeat every 3 week absence disease progression unacceptable toxicity . Patients follow survival . PROJECTED ACCRUAL : At total 15-46 patient accrue study .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<mesh_term>Mitomycin</mesh_term>
	<mesh_term>Mitomycins</mesh_term>
	<mesh_term>Vinorelbine</mesh_term>
	<mesh_term>Tretinoin</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Histologically confirm stage IIIB IV nonsmall cell lung cancer Measurable disease No brain metastasis PATIENT CHARACTERISTICS : Age : Over 18 Performance status : Zubrod 02 Life expectancy : Not specify Hematopoietic : Absolute granulocyte count great 2,000/mm^3 Platelet count great 100,000/mm^3 Hepatic : Bilirubin le 2 time upper limit normal ( ULN ) AST ALT less 2.5 time ULN ( unless attribute liver metastasis ) Renal : Creatinine great 1.5 mg/dL AND/OR Creatinine clearance least 60 mL/min Cardiovascular : No myocardial infarction within past 6 month No congestive heart failure No uncontrolled arrhythmia Other : No concurrent prior malignancy within past 5 year except localize basal cell squamous cell skin cancer Not pregnant nursing Negative pregnancy test Fertile patient must use effective contraception HIV negative PRIOR CONCURRENT THERAPY : Biologic therapy : Not specify Chemotherapy : No prior chemotherapy Endocrine therapy : Not specify Radiotherapy : At least 4 week since prior radiotherapy clearly progressive disease Concurrent palliative radiotherapy allow evidence disease progression Surgery : Not specify</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2003</verification_date>
	<keyword>stage IIIB non-small cell lung cancer</keyword>
	<keyword>stage IV non-small cell lung cancer</keyword>
</DOC>